Avanos Medical

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$179,600
$170,400
$171,700
$166,100
Gross Profit
98,000
92,900
95,600
94,800
EBITDA
-406,600
24,400
23,000
18,900
EBIT
-417,700
12,700
11,700
7,500
Net Income
-397,300
4,300
1,800
-900
Net Change In Cash
179,600
170,400
171,700
166,100
Free Cash Flow
53,100
20,000
21,900
-12,099
Cash
107,700
89,000
92,200
75,800
Basic Shares
46,000
46,600
46,300
46,200

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$687,800
$673,300
$820,000
$744,600
Gross Profit
381,300
379,700
450,000
364,300
EBITDA
-345,600
50,600
77,800
8,900
EBIT
-391,100
4,500
36,700
-29,400
Net Income
-392,100
-61,800
50,500
6,300
Net Change In Cash
687,800
673,300
820,000
744,600
Cost of Revenue
12,200
11,000
Free Cash Flow
82,900
14,600
71,600
66,300
Cash
107,700
87,700
127,700
118,500
Basic Shares
46,000
46,600
47,300
48,600

Earnings Calls

Quarter EPS
2024-12-31
$0.43
2024-09-30
$0.36
2024-06-30
$0.29
2024-03-31
$0.19